updates in extended endocrine therapy for hr breast cancer | asco21 & national practice guidelines
Published 3 years ago • 1.5K plays • Length 1:10:36Download video MP4
Download video MP3
Similar videos
-
41:53
guideline updates for extended endocrine therapy decision-making in hr , early-stage breast cancer
-
53:42
guideline updates for extended endocrine therapy decision-making in hr , early-stage breast cancer
-
16:19
breast cancer index, extended endocrine therapy | elizabeth ott, pa | 2022 west oncology app updates
-
33:11
recent updates in hr-positive/her2-negative early breast cancer: a deep dive into understanding t...
-
1:56
exploring extended adjuvant endocrine therapy for hr breast cancer
-
57:06
neoadjuvant endocrine therapy in breast cancer
-
8:30
hr breast cancer: endocrine therapy, surgery and radiotherapy
-
1:09:24
raising the bar in hr /her2- early breast cancer: cdk4 and 6 inhibitors
-
57:18
navigating the expanding treatment arsenal for er /her2- breast cancer
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
2:55
e2112: endocrine therapy plus entinostat in hr advanced breast cancer
-
6:35
extended endocrine therapy: who will benefit?
-
30:56
adjuvant treatment for early stage hormone positive breast cancer: role of genomic signatures
-
1:12
dr. joseph sparano on the role of endocrine therapy in breast cancer
-
25:02
advanced stage hormone positive breast cancer fine tuning sequential endocrine and targeted therapy
-
1:30
exploring endocrine therapy innovations for high-risk hormone receptor-positive breast cancer
-
6:29
study of palbociclib after cdk & endocrine therapy in er /her2- metastatic breast cancer
-
1:55
dr. judy boughey on neoadjuvant endocrine therapy in breast cancer
-
2:47
adjuvant endocrine therapy in premenopausal breast cancer: 12-year results from soft